Specific type IV pili groups in clinical isolates of Pseudomonas aeruginosa

Gertrudis Horna1,2, Karina Quezada3, Susan Ramos3

  • 1Barcelona Institute for Global Health, ISGlobal, Hospital Clínic - Universitat de Barcelona, building CEK, C/Rosselló 149-153, 08036, Barcelona, Spain. gertrudis.horna@isglobal.org.

Insights

Specific type IV pili (TFP) groups influence Pseudomonas aeruginosa biofilm formation and motility. TFP group III correlates with strong biofilm production and multidrug resistance in clinical isolates.

Area of Science:

  • Microbiology
  • Bacterial Genetics

Background:

  • Pseudomonas aeruginosa is an opportunistic pathogen known for its adaptability.
  • Type IV pili (TFP) are crucial for various bacterial surface-associated behaviors.
  • Understanding TFP roles in virulence factors like biofilm and motility is clinically relevant.

Purpose of the Study:

  • To investigate the association between specific TFP groups and key P. aeruginosa phenotypes.
  • To determine the relationship between TFP, antibiotic resistance, biofilm formation, and motility in clinical isolates.

Main Methods:

  • Phenotypic assays for biofilm formation and motility.
  • Polymerase Chain Reaction (PCR) for TFP detection.
  • Disk diffusion method for antibiotic susceptibility testing.
  • Analysis of 190 clinical P. aeruginosa isolates.

Main Results:

  • High prevalence of biofilm formation (97.4%) and multidrug resistance (44.7%) observed.
  • Strong biofilm production was associated with multidrug resistance.
  • TFP group III linked to strong biofilm production; TFP group II and absence of TFP linked to weaker biofilm formation.
  • Distinct motility patterns observed: TFP group II associated with increased swarming, swimming, and twitching; TFP groups I and III showed reduced motility.

Conclusions:

  • Specific TFP groups significantly modulate P. aeruginosa biofilm production and motility.
  • TFP group III is associated with enhanced biofilm formation and multidrug resistance.
  • Findings underscore the clinical significance of TFP diversity in P. aeruginosa pathogenesis.

Related Concept Videos

Type IV Collagen of Basal Lamina01:05

Type IV Collagen of Basal Lamina

Type IV collagen is a 400 nm long, network-forming collagen that acts as a barrier between the epithelial and endothelial cells. Type IV collagen  forms the backbone of the basement membrane by scaffolding with laminin, entactin, proteoglycans, and fibronectin. Apart from rendering structural support to the basement membrane, it also helps entail signaling potentials necessary for both pathological and physiological functions.
A type IV collagen molecule has six alpha chains which can...
3.1K
Fimbriae, Pili, and Axial Filaments01:28

Fimbriae, Pili, and Axial Filaments

Fimbriae and pili are specialized bacterial surface structures that play pivotal roles in adhesion, genetic exchange, and motility. Composed primarily of pilin protein, these hairlike appendages are crucial for bacterial survival and pathogenicity in various environments.Fimbriae: Adhesion and PathogenicityFimbriae are fine, filamentous structures measuring 2–10 nanometers in diameter and are densely distributed on the bacterial cell surface. They facilitate bacterial adhesion to abiotic...
1.8K
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
215
Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
72.8K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
807
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
514